Clinical trials for Leiomyosarcoma
30 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07125183Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic LeiomyosarcomaUniversity of Colorado, Denver · PI: Breelyn Wilky, MD
- ENROLLING BY INVITATIONN/ANCT07405346A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized EfficacyUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGPhase 1NCT06957431Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and LeiomyosarcomaWashington University School of Medicine · PI: Mia C Weiss, M.D.
- RECRUITINGPhase 2NCT07076186Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMSM.D. Anderson Cancer Center · PI: Elise Nassif Haddad, MD
- RECRUITINGPhase 2NCT06528769Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced LeiomyosarcomaGabriel Tinoco · PI: Gabriel Tinoco, MD
- RECRUITINGPhase 2NCT06524583Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the TumourUNICANCER · PI: Florence DUFFAUD, MD
- RECRUITINGPhase 2NCT06571734XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable LeiomyosarcomaNorthwestern University · PI: Pedro Hermida de Viveiros, MD
- RECRUITINGPhase 1NCT06308419A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or DeletionsM.D. Anderson Cancer Center · PI: Elise Nassif, MD
- RECRUITINGPhase 2NCT05649956Letrozole in Uterine LeiomyosarcomaGOG Foundation · PI: Bradley Corr, MD
- RECRUITINGNCT06875700Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatientsUniversity of Utah
- RECRUITINGNCT06749600Clinical Management and Outcomes of Primary Ovarian LeiomyosarcomaAzienda USL Reggio Emilia - IRCCS
- RECRUITINGPhase 3NCT05712694Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)Polaris Group · PI: John S Bomalaski
- RECRUITINGPhase 3NCT06088290Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)PharmaMar
- ACTIVE NOT RECRUITINGN/ANCT06244251Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine FibroidsWest China Second University Hospital
- RECRUITINGNCT04925089Localized Leiomyosarcoma Biomarker ProtocolUniversity of Michigan Rogel Cancer Center · PI: Scott Schuetze
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05432791Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped WorkingNational Cancer Institute (NCI) · PI: Matthew Ingham
- ACTIVE NOT RECRUITINGN/ANCT05427461Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2Institut Claudius Regaud
- RECRUITINGNCT05653388Metastatic Leiomyosarcoma Biomarker ProtocolUniversity of Michigan Rogel Cancer Center · PI: Scott Schuetze
- RECRUITINGPhase 1NCT05227326AOH1996 for the Treatment of Refractory Solid TumorsCity of Hope Medical Center · PI: Vincent Chung, MD
- RECRUITINGPhase 2NCT04807816Targeting ATR in Soft-tissue SarcomasInstitut Bergonié
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05099666Lurbinectedin + Doxorubicin In LeiomyosarcomaMassachusetts General Hospital · PI: Gregory Cote, M.D. Ph.D
- RECRUITINGPhase 2NCT04383119Trial in Patients With Metastatic or Locally Advanced LeiomyosarcomaItalian Sarcoma Group · PI: Bruno Vincenzi, Prof/MD
- RECRUITINGPhase 2NCT04535271Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue SarcomaSarcoma Oncology Research Center, LLC · PI: Sant P Chawla, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04727242CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine LeiomyosarcomaStanford University · PI: Kristen N Ganjoo, MD
- RECRUITINGPhase 3NCT04031677Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaEuropean Organisation for Research and Treatment of Cancer - EORTC
- ACTIVE NOT RECRUITINGPhase 2NCT04624178A Study of Rucaparib and Nivolumab in People With LeiomyosarcomaMemorial Sloan Kettering Cancer Center · PI: Sujana Movva, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04200443Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue SarcomaCity of Hope Medical Center · PI: Janet Yoon, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03880019A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine LeiomyosarcomaNational Cancer Institute (NCI) · PI: Mia C Weiss
- ACTIVE NOT RECRUITINGPhase 2NCT03851614Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid TumorsUniversity Health Network, Toronto · PI: Lillian Siu, MD
- RECRUITINGNCT06170177Study on the Quality of Life and Pathological State in Patients Who Underwent Radical CystectomyIRCCS San Raffaele · PI: Francesco Montorsi, MD